Induction of heme oxygenase-1 attenuates lipopolysaccharide-induced cyclooxygenase-2 expression in mouse brain endothelial cells

Springer Science and Business Media LLC - Tập 7 - Trang 1-10 - 2010
Ruey-Horng Shih1, Chuen-Mao Yang1
1Department of Physiology and Pharmacology, Chang Gung University, Kwei-San

Tóm tắt

Prostaglandin E2 (PGE2), an arachidonic acid metabolite converted by cyclooxygenase-2 (COX-2), plays important roles in the regulation of endothelial functions in response to bacterial infection. The enzymatic activity of COX-2 can be down-regulated by heme oxygenase-1 (HO-1) induction. However, the mechanisms underlying HO-1 modulating COX-2 protein expression are not known. The aim of the present study was to investigate whether the up-regulation of HO-1 regulates COX-2 expression induced by lipopolysaccharide (LPS), an endotoxin produced by Gram negative bacteria, in mouse brain endothelial cells (bEnd.3) Cultured bEnd.3 cells were used to investigate LPS-induced COX-2 expression and PGE2 production. Cobalt protoporphyrin IX (CoPP, an HO-1 inducer), infection with a recombinant adenovirus carried with HO-1 gene (Adv-HO-1), or zinc protoporphyrin (ZnPP, an HO-1 inhibitor) was used to stimulate HO-1 induction or inhibit HO-1 activity. The expressions of COX-2 and HO-1 were evaluated by western blotting. PGE2 levels were detected by an enzyme-linked immunoassay. Hemoglobin (a chelator of carbon monoxide, CO, one of metabolites of HO-1) and CO-RM2 (a CO releasing molecule) were used to investigate the mechanisms of HO-1 regulating COX-2 expression. We found that LPS-induced COX-2 expression and PGE2 production were mediated through NF-κB (p65) via activation of Toll-like receptor 4 (TLR4). LPS-induced COX-2 expression was inhibited by HO-1 induction by pretreatment with CoPP or infection with Adv-HO-1. This inhibitory effect of HO-1 was reversed by pretreatment with either ZnPP or hemoglobin. Pretreatment with CO-RM2 also inhibited TLR4/MyD88 complex formation, NF-κB (p65) activation, COX-2 expression, and PGE2 production induced by LPS. We show here a novel inhibition of HO-1 on LPS-induced COX-2/PGE2 production in bEnd.3. Our results reinforce the emerging role of cerebral endothelium-derived HO-1 as a protector against cerebral vascular inflammation triggered by bacterial infection.

Tài liệu tham khảo

Cohen J: The immunopathogenesis of sepsis. Nature. 2002, 420: 885-891. 10.1038/nature01326. Su GL, Klein RD, Aminlari A, Zhang HY, Steinstraesser L, Alarcon WH, Remick DG, Wang SC: Kupffer cell activation by lipopolysaccharide in rats: role for lipopolysaccharide binding protein and toll-like receptor 4. Hepatology. 2000, 31: 932-936. 10.1053/he.2000.5634. Ejima K, Layne MD, Carvajal IM, Kritek PA, Baron RM, Chen YH, Vom Saal J, Levy BD, Yet SF, Perrella MA: Cyclooxygenase-2-deficient mice are resistant to endotoxin-induced inflammation and death. FASEB J. 2003, 17: 1325-1327. Fletcher JR: Eicosanoids: critical agents in the physiological process and cellular injury. Arch Surg. 1993, 128: 1192-1196. Williams JA, Shacter E: Regulation of macrophage cytokine production by prostaglandin E2: distinct roles of cyclooxygenase-1 and -2. J Biol Chem. 1997, 272: 25693-25699. 10.1074/jbc.272.41.25693. Eklind S, Mallard C, Leverin AL, Gilland E, Blomgren K, Mattsby-Baltzer I, Hagberg H: Bacterial endotoxin sensitizes the immature brain to hypoxic-ischemic injury. Eur J Neurosci. 2001, 13: 1101-1106. 10.1046/j.0953-816x.2001.01474.x. Fan LW, Pang Y, Lin S, Rhodes PG, Cai Z: Minocycline attenuates lipopolysaccharide-induced white matter injury in the neonatal rat brain. Neuroscience. 2005, 133: 1359-1368. 10.1016/j.neuroscience.2005.02.016. Fan LW, Mirchell HJ, Tien LT, Zheng B, Pang Y, Rhodes PG, Cai Z: Alpha-phenyl-n-tert-butyl-nitrone reduces lipopolysaccharide-induced white matter injury in the neonatal rat brain. Dev Neurobiol. 2008, 68: 365-378. 10.1002/dneu.20591. Wang X, Rousset CI, Hagberg H, Mallard C: Lipopolysaccharide-induced inflammation and perinatal brain injury. Semin Fetal Neonatal Med. 2006, 11: 343-353. 10.1016/j.siny.2006.04.002. Brouard S, Otterbein LE, Anrather J, Tobiasch E, Bach FH, Choi AM: Carbon monoxide generated by heme oxygenase-1 suppresses endothelial cell apoptosis. J Exp Med. 2000, 192: 1015-1026. 10.1084/jem.192.7.1015. Nakao A, Kaczorowski DJ, Zuckerbraun BS, Lei J, Faleo G, Deguchi K, McCurry KR, Billiar TR, Kanno S: Galantamine and carbon monoxide protect brain microvascular endothelial cells by heme oxygenase-1 induction. Biochem Biophys Res Commun. 2008, 367: 674-679. 10.1016/j.bbrc.2007.12.152. Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H, Toma T, Ohta K, Kasahara Y, Koizumi S: Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest. 1999, 103: 129-135. 10.1172/JCI4165. Alcaraz MJ, Fernandez P, Guillen MI: Anti-inflammatory actions of the heme oxygenase-1 pathway. Curr Pharm Des. 2003, 9: 2541-2551. 10.2174/1381612033453749. Bauer I, Wanner GA, Rensing H, Alte C, Miescher EA, Wolf B, Pannen BH, Clemens MG, Bauer M: Expression pattern of heme oxygenase isoenzymes 1 and 2 in normal and stress-exposed rat liver. Hepatology. 1998, 27: 829-838. 10.1002/hep.510270327. Ryter SW, Alam J, Choi AM: Heme oxygenase/carbon monoxide: from basic science to therapeutic application. Physiol Rev. 2006, 86: 583-650. 10.1152/physrev.00011.2005. Bernardini C, Zannoni A, Bacci ML, Forni M: Protective effect of carbon monoxide pre-conditioning on LPS-induced endothelial cell stress. Cell Stress Chaperones. 2010, 15: 219-24. 10.1007/s12192-009-0136-7. Seed MP, Willoughby DA: COX-2, HO NO! Cyclooxygenase-2, heme oxygenase and nitric oxide synthase: their role and interactions in inflammation. Inflamm Res. 1997, 46: 279-281. 10.1007/s000110050187. Wagener FA, Volk HD, Willis D, Abraham NG, Soares MP, Adema GJ, Figdor CG: Different faces of the heme-heme oxygenase system in inflammation. Pharmacol Rev. 2003, 55: 551-571. 10.1124/pr.55.3.5. Lee CW, Chien CS, Yang CM: Lipoteichoic acid-stimulated p42/p44 MAPK activation via Toll-like receptor 2 in tracheal smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 2004, 286: L921-L930. 10.1152/ajplung.00124.2003. Hsieh HL, Wu CY, Hwang TL, Yen MH, Parker P, Yang CM: BK-induced cytosolic phospholipase A2 expression via sequential PKC-δ, p42/p44 MAPK, and NF-κB activation in rat brain astrocytes. J Cell Physiol. 2006, 206: 246-254. 10.1002/jcp.20457. Tenhunen R, Marver HS, Schmid R: The enzymatic catabolism of hemoglobin: stimulation of microsomal heme oxygenase by hemin. J Lab Clin Med. 1970, 75: 410-421. Nakao S, Ogata Y, Shimizu-Sasaki E, Yamazaki M, Furuyama S, Sugiya H: Activation of NF-κB is necessary for IL-1β-induced cyclooxygenase-2 (COX-2) expression in human gingival fibroblasts. Mol Cell Biochem. 2000, 209: 113-118. 10.1023/A:1007155525020. Dauphinee SM, Karsan A: Lipopolysaccharide signaling in endothelial cells. Lab Invest. 2006, 86: 9-22. 10.1038/labinvest.3700366. Li Volti G, Seta F, Schwartzman ML, Nasjletti A, Abraham NG: Heme oxygenase attenuates angiotensin II-mediated increase in cyclooxygenase-2 activity in human femoral endothelial cells. Hypertension. 2003, 41: 715-719. 10.1161/01.HYP.0000049163.23426.66. Megías J, Guillén MI, Clérigues V, Rojo AI, Cuadrado A, Castejón MA, Gomar F, Alcaraz MJ: Heme oxygenase-1 induction modulates microsomal prostaglandin E synthase-1 expression and prostaglandin E2 production in osteoarthritic chondrocytes. Biochem Pharmacol. 2009, 77: 1806-1813. 10.1016/j.bcp.2009.03.009. Tsoyi K, Kim HJ, Shin JS, Kim DH, Cho HJ, Lee SS, Ahn SK, Yun-Choi HS, Lee JH, Seo HG, Chang KC: HO-1 and JAK-2/STAT-1 signals are involved in preferential inhibition of iNOS over COX-2 gene expression by newly synthesized tetrahydroisoquinoline alkaloid, CKD712, in cells activated with lipopolysacchride. Cell Signal. 2008, 20: 1839-1847. 10.1016/j.cellsig.2008.06.012. Wen T, Wu ZM, Liu Y, Tan YF, Ren F, Wu H: Upregulation of heme oxygenase-1 with hemin prevents D-galactosamine and lipopolysaccharide-induced acute hepatic injury in rats. Toxicology. 2007, 237: 184-193. 10.1016/j.tox.2007.05.014. Alcaraz MJ, Guillen MI, Ferrandiz ML, Megias J, Motterlini R: Carbon monoxide-releasing molecules: a pharmacological expedient to counteract inflammation. Curr Pharm Des. 2008, 14: 465-472. 10.2174/138161208783597362. Chung SW, Liu X, Macias AA, Baron RM, Perrella MA: Heme oxygenase-1-derived carbon monoxide enhances the host defense response to microbial sepsis in mice. J Clin Invest. 2008, 118: 239-247. 10.1172/JCI32730. Morse D, Pischke SE, Zhou Z, Davis RJ, Flavell RA, Loop T, Otterbein SL, Otterbein LE, Choi AM: Suppression of inflammatory cytokine production by carbon monoxide involves the JNK pathway and AP-1. J Biol Chem. 2003, 278: 36993-36998. 10.1074/jbc.M302942200. Sarady JK, Otterbein SL, Liu F, Otterbein LE, Choi AM: Carbon monoxide modulates endotoxin-induced production of granulocyte macrophage colony-stimulating factor in macrophages. Am J Respir Cell Mol Biol. 2002, 27: 739-745. Sun B, Zou X, Chen Y, Zhang P, Shi G: Preconditioning of Carbon Monoxide Releasing Molecule-derived CO Attenuates LPS-induced Activation of HUVEC. Int J Biol Sci. 2008, 4: 270-278. Ryter SW, Otterbein LE, Morse D, Choi AM: Heme oxygenase/carbon monoxide signaling pathways: Regulation and functional significance. Mol Cell Biochem. 2002, 234-235: 249-263. 10.1023/A:1015957026924. Wang XM, Kim HP, Nakahira K, Ryter SW, Choi AM: The heme oxygenase-1/carbon monoxide pathway suppresses TLR4 signaling by regulating the interaction of TLR4 with caveolin-1. J Immunol. 2009, 182: 3809-3818. 10.4049/jimmunol.0712437. Chhikara M, Wang S, Kern SJ, Ferreyra GA, Barb JJ, Munson PJ, Danner RL: Carbon monoxide blocks lipopolysaccharide-induced gene expression by interfering with proximal TLR4 to NF-κB signal transduction in human monocytes. PLoS ONE. 2009, 4: e8139-10.1371/journal.pone.0008139. Suh GY, Jin Y, Yi AK, Wang XM, Choi AM: CCAAT/enhancer-binding protein mediates carbon monoxide-induced suppression of cyclooxygenase-2. Am J Respir Cell Mol Biol. 2006, 35: 220-226. 10.1165/rcmb.2005-0154OC. Kaizaki A, Tanaka S, Ishige K, Numazawa S, Yoshida T: The neuroprotective effect of heme oxygenase (HO) on oxidative stress in HO-1 siRNA-transfected HT22 cells. Brain Res. 2006, 1108: 39-44. 10.1016/j.brainres.2006.06.011. Weihong Pan , Chuanhui Yu , Hung Hsuchou , Kastin Abba: The role of cerebral vascular NF-κB in LPS-induced inflammation: Differential regulation of efflux transporter and transporting cytokine receptors. Cell Physiol Biochem. 2010, 25: 623-630. 10.1159/000315081. Ndisang JF, Jadhav A: Heme oxygenase system enhances insulin sensitivity and glucose metabolism in streptozotocin-induced diabetes. Am J Physiol Endocrinol Metab. 2009, 296: E829-E841. 10.1152/ajpendo.90783.2008. Cheng S, Afif H, Martel-Pelletier J, Pelletier JP, Li X, Farrajota K: Activation of peroxisome proliferator-activated receptor-γ inhibits interleukin-1β-induced membrane-associated prostaglandin E2 synthase-1 expression in human synovial fibroblasts by interfering with Egr-1. J Biol Chem. 2004, 279: 22057-22065. 10.1074/jbc.M402828200. Megías J, Guillén MI, Clérigues V, Rojo AI, Cuadrado A, Castejón MA, Gomar F, Alcaraz MJ: Heme oxygenase-1 induction modulates microsomal prostaglandin E synthase-1 expression and prostaglandin E2 production in osteoarthritic chondrocytes. Biochem Pharmacol. 2009, 77: 1806-1813. 10.1016/j.bcp.2009.03.009. Alcaraz MJ, Fernandez P, Guillen MI: Anti-inflammatory actions of the heme oxygenase-1 pathway. Curr Pharm Des. 2003, 9: 2541-2551. 10.2174/1381612033453749. Brouard S, Otterbein LE, Anrather J, Tobiasch E, Bach FH, Choi AM: Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med. 2000, 192: 1015-1026. 10.1084/jem.192.7.1015. Akira S, Takeda K: Toll-like receptor signalling. Nat Rev Immunol. 2004, 4: 499-511. 10.1038/nri1391. Wang XM, Kim HP, Nakahira K, Ryter SW, Choi AMK: The heme oxygenase-1/carbon monoxide pathway suppresses TLR4 signaling by regulating the interaction of TLR4 with caveolin-1. J Immunol. 2009, 182: 3809-3818. 10.4049/jimmunol.0712437. Araki E, Forster C, Dubinsky JM, Ross ME, Iadecola C: Cyclooxygenase-2 inhibitor NS-398 protects neuronal cultures from lipopolysaccharide-induced neurotoxicity. Stroke. 2001, 32: 2370-2375. 10.1161/hs1001.096057. Alcaraz MJ, Habib A, Cre´minon C, Vicente AM, Lebret M, Le´vy-Toledano S, Maclouf J: Heme oxygenase-1 induction by nitric oxide in RAW 264.7 macrophages is upregulated by a cyclo-oxygenase-2 inhibitor. Biochim Biophys Acta. 2001, 1526: 13-16. Fernández P, Guillén MI, Gomar F, Aller E, Molina P, Alcaraz MJ: A novel cyclo-oxygenase-2 inhibitor modulates catabolic and anti-inflammatory mediators in osteoarthritis. Biochem Pharmacol. 2004, 68: 417-421. 10.1016/j.bcp.2004.03.038. Han S, Roman J: COX-2 inhibitors suppress lung cancer cell growth by inducing p21 via COX-2 independent signals. Lung Cancer. 2006, 51: 283-296. 10.1016/j.lungcan.2005.10.015. Park MK, Kang YJ, Ha YM, Jeong JJ, Kim HJ, Seo HG, Lee JH, Chang KC: EP2 receptor activation by prostaglandin E2 leads to induction of HO-1 via PKA and PI3K pathways in C6 cells. Biochem Biophys Res Commun. 2009, 379: 1043-1047. 10.1016/j.bbrc.2009.01.005.